Compound Artemisia Analgin Tablets

This product is a compound antipyretic and analgesic drug with antipyretic and analgesic effects.

Analgin, chlorpheniramine maleate, Artemisia annua.

This product is white tablets.

Used for fever, nasal congestion, sore throat, aching limbs, and symptoms caused by influenza.

Oral, 4-6 tablets at a time, 3-4 times a day

1. Occasionally it may cause allergic rash and drug fever, including urticaria, exudative erythema, etc. In severe cases, it may cause exfoliative dermatitis and bullous epidermolysis; 2. Occasionally, respiratory and circulatory failure may occur due to anaphylactic shock; 3. After long-term use, it may cause granulocytopenia and thrombocytopenia, and in severe cases, aplastic anemia may occur; 4. Occasionally, vomiting, oral ulcers, glans erosion, etc.

It is contraindicated for patients with a history of allergy to this product or other pyrazolones, as well as those who are allergic to aspirin and other non-steroidal anti-inflammatory drugs.

Precautions for children: Children should use with caution. The dosage can be halved as appropriate, but it must be used under adult supervision. Or follow the doctor's advice. Precautions for pregnancy and lactation: Pregnant and lactating women should use with caution. Precautions for the elderly: The elderly should use this drug with caution due to decreased liver and kidney function. Elderly patients with heart disease, hypertension, diabetes, prostate hypertrophy, etc. should use it with caution.

1. Avoid using it in combination with chloramphenicol, as it may cause leukopenia; 2. It may enhance the cooling effect of chlorpromazine, leading to severe hypothermia, and should not be used in combination; 3. It may enhance the effect of anticoagulants.

Keep away from light and store in sealed container.

0.4g

24 months

Chengdu Brilliant Pharmaceutical Co., Ltd.

• Founded in:

  1995-10-10

• Address:

  No. 263, Hexiang 3rd Street, Chengdu Hi-tech Zone

• Tax NO.:

  91510100633104205M

• Registered Funds:

  450 million yuan

• Website:

  Log in to view

• Email:

  Log in to view